UYSAL, M. Et Al. 2012. Proteinuria As A Predictive Factor İn Metastatic Colorectal Cancer Patients Treated With Bevacizumab. 2012 ASCO Annual Meeting , (Chicago, United States Of America), 14070.

UYSAL, M., Bozcuk, H., Sema Sezgin, G., TATLI, A. M., Arslan, D., Gülenay Gündüz, Ş., ... COŞKUN, H. Ş.(2012). Proteinuria As A Predictive Factor İn Metastatic Colorectal Cancer Patients Treated With Bevacizumab . 2012 ASCO Annual Meeting (pp.14070). Chicago, United States Of America

UYSAL, MÜKREMİN Et Al. "Proteinuria As A Predictive Factor İn Metastatic Colorectal Cancer Patients Treated With Bevacizumab," 2012 ASCO Annual Meeting, Chicago, United States Of America, 2012

UYSAL, MÜKREMİN Et Al. "Proteinuria As A Predictive Factor İn Metastatic Colorectal Cancer Patients Treated With Bevacizumab." 2012 ASCO Annual Meeting , Chicago, United States Of America, pp.14070, 2012

UYSAL, M. Et Al. (2012) . "Proteinuria As A Predictive Factor İn Metastatic Colorectal Cancer Patients Treated With Bevacizumab." 2012 ASCO Annual Meeting , Chicago, United States Of America, p.14070.

@conferencepaper{conferencepaper, author={MÜKREMİN UYSAL Et Al. }, title={Proteinuria As A Predictive Factor İn Metastatic Colorectal Cancer Patients Treated With Bevacizumab}, congress name={2012 ASCO Annual Meeting}, city={Chicago}, country={United States Of America}, year={2012}, pages={14070} }